+86-531-88916568
History
Home » Company » History
  • Jun.2020
    • Expanded monthly production capacity of Betadex Sulfobutyl Ether Sodium.

  • Apr.2020
    • New extended R & D Center was established in Jinan.

  • May.2018
    • GMP workshop renovation and extension project finished.

  • Aug.2016
    • Betadex Sulfobutyl Ether Sodium obtained drug clinical trial approval.

  • Dec.2015
    • Hydroxypropyl Betadex was approved by the U.S FDA, DMF NO.:030168.
      Betadex Sulfobutyl Ether Sodium was approved by the U.S FDA, DMF NO.:030167.

  • May.2015
    • Betadex Sulfobutyl Ether Sodium obtained new drug registration application.

      Obtained Kosher and HALAL certification.

  • Mar.2015
    • Hydroxypropyl Betadex obtained approval for the registration of pharmaceutical excipients.

  • Sep.2014
    • Commenced production of cyclodextrin inclusion compounds-Piroxicam-beta -cyclodextrin Complex, etc.

  • Mar.2014
    • Obtained the drug production license.

  • Jun.2013
    • Obtained ISO9001 certification.

  • Sep.2010
    • Commenced production of Cyclodextrin derivatives - Hydroxypropyl Betadex, Betadex Sulfobutyl Ether Sodium, Methy Beta Cyclodextrin, etc.

  • Jul.2010
    • Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd was established in Boxing Economic Development Zone, Binzhou, Shandong, China.

PRODUCT CATEGORY

QUICK LINKS

CONTACT INFORMATION

Tel: +86-531-88916568
 Mail: enquiry@cydextrin.com
​​​​​​​ Address: Boxing Economic Development Zone, Binzhou, Shandong, China.

FREE CONSULTATION

Contact us
© 2020 Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. All rights reserved. Sitemap